Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
228 Results for "
hcc
" in MedChemExpress (MCE) Product Catalog:
Products (228)
228 Results for "hcc" in MCE Product Catalog:
4
3
3 Cited Publications
Cat. No.: HY-N0070
CAS No.: 19121-58-5
2
Chromeceptin (94G6) is an IGF signaling pathway inhibitor. Chromeceptin suppresses IGF2 expression at mRNA and protein levels in hepatocyte and HCC cells. Chromeceptin inhibits the phosphorylation levels of AKT and mTOR .
2
2 Cited Publications
Cat. No.: HY-P99353
CAS No.: 1463459-96-2
Synonyms: Anti-ACVRL1 / ALK-1 Reference Antibody (ascrinvacumab); PF-03446962; GT-90001C
Target:
Research Areas:
2
2 Cited Publications
Target:
Research Areas:
LDN-212854 is a bone morphogenetic protein (BMP) inhibitor that potently inhibits ALK2 (IC50: 1.3 nM). LDN-212854 also inhibits ALK1 (IC50: 2.40 nM). LDN-212854 can be used in the research of fibrodysplasia ossificans progressive and cancers, such as hepatocellular carcinoma (HCC) .
2
2 Cited Publications
STAT3-IN-12 is a potent STAT3 signal inhibitor that can inhibit IL-6 induced JAK/STAT3 signalling pathway activation. STAT3-IN-12 inhibits cancer cell growth, migration, and induce cell apoptosis as well as cycle arrest. STAT3-IN-12 can be used in cancer-related research, such as hepatocellular carcinoma (HCC) and oesophageal carcinoma .
2
Target:
Research Areas:
Vevorisertib (ARQ 751) is an orally active allosteric AKT inhibitor that blocks AKT phosphorylation. Vevorisertib inhibits tumor cell proliferation through Cyclin D1 and Ki67. Vevorisertib inhibits liver fibrosis through collagen accumulation, alpha-SMA, COL1, and TGF-beta. Vevorisertib reduces total bilirubin. Vevorisertib significantly reduces tumor size in a cirrhotic rat HCC model. Vevorisertib can be used for research on hepatocellular carcinoma .
2
2 Cited Publications
Synonyms: ARQ 751 trihydrochloride
Target:
Research Areas:
Vevorisertib trihydrochloride (ARQ 751 trihydrochloride) is an orally active allosteric AKT inhibitor that blocks AKT phosphorylation. Vevorisertib trihydrochloride inhibits tumor cell proliferation through Cyclin D1 and Ki67. Vevorisertib trihydrochloride inhibits liver fibrosis through collagen accumulation, alpha-SMA, COL1, and TGF-beta. Vevorisertib trihydrochloride reduces total bilirubin. Vevorisertib trihydrochloride significantly reduces tumor size in a cirrhotic rat HCC model. Vevorisertib trihydrochloride can be used for research on hepatocellular carcinoma .
1
1 Cited Publications
Cat. No.: HY-N6623
CAS No.: 30113-37-2
1
Target:
Research Areas:
α-L-Fucosidase, Microorganism (EC 3.2.1.51) is an enzyme that catalyzes the chemical reaction. Serum activity of α-L-Fucosidase, Microorganism, a lysosomal enzyme present in all mammalian cells, has been proposed as a marker of hepatocellular carcinoma (HCC) .
1
WNTinib (APS-8-100-2) is a multi-kinase inhibitor that selectively antagonizes β-catenin (CTNNB1) mutated hepatocellular carcinoma (HCC). WNTinib downregulates oncogenicWntsignaling by inhibiting KIT/MAPK and downstream EZH2 activation .
1
1 Cited Publications
Cat. No.: HY-P11050
CAS No.: 1309883-67-7
Target:
Research Areas:
1
1 Cited Publications
Cat. No.: HY-P7763
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CCL14; C-C Motif Chemokine 14; Prev. SCYA14; hcc-1(1-74); NCC-2; hcc-1/hcc-3; hcc-1; NCC2; hcc-3; Hemofiltrate CC Chemokine 1; SCYL2; C-C Motif Chemokine; CKb1; New CC Chemokine 2; MCIF; Chemokine CC-3; Small Inducible Cytokine Subfamily A (Cys-Cys), Memb
Species:
Human
Source:
HEK293
1
1 Cited Publications
Cat. No.: HY-P7196
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CCL16; Small-Inducible Cytokine A16; Prev. SCYA16; Liver-Expressed Chemokine; LCC-1; C-C Motif Chemokine 16; hcc-4; Chemokine LEC; NCC-4; Monotactin-1; LMC; ILINCK; Mtn-1; NCC4; CKb12; Liver CC Chemokine-1; SCYL4; C-C Motif Chemokine; LEC; New CC Chemokin
Species:
Human
Source:
CHO
1
Target:
Research Areas:
Codrituzumab (GC33) is a humanized monoclonal antibody targeting human GPC3 (glypican-3), with high affinity (Kd of 0.673 nM). GPC3 is an oncofetal protein expressed on the cell surface of hepatocellular carcinoma (HCC). Codrituzumab induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth .
1
1 Cited Publications
Category:
Infection Microorganisms Macrolide Antibiotics Antibiotics Disease Research Antibacterial Anticancer Disease Research Fields Cancer
Target:
1
1 Cited Publications
Target:
Research Areas:
Anticancer agent 73 (compound CIB-3b) is a anticancer agent, potently targeting TAR RNA-binding protein 2 (TRBP) and disrupts its interaction with Dicer. Anticancer agent 73 can rebalance the expression profile of oncogenic or tumor-suppressive miRNAs. Anticancer agent 73 suppresses the proliferation and metastasis of HCC in vitro and in vivo .
1
1 Cited Publications
Target:
Research Areas:
Zardaverine is an orally active and selective PDE3/4 inhibitor (IC50)=0.58 uM/0.17 uM) with potent bronchodilator activity. Zardaverine also selectively inhibits the proliferation of HCC cells and induces apoptosis and cycle arrest (G0/G1 phase). Zardaverine has good antitumor potential and is effective in both bronchial relaxation and reduction of inflammation in asthma .
1
1 Cited Publications
Cat. No.: HY-N6739
CAS No.: 26048-05-5
1
1 Cited Publications
Target:
Research Areas:
JMJD6-IN-1 is a JMJD6 inhibitor, with an inhibition rate of 82% at 10 μM. JMJD6-IN-1 inhibits MCF-7 and HCC4006 cell proliferation with IC50 values of 19.2 μM and 25.2 μM. JMJD6-IN-1 inhibits JMJD6 demethylase activity. JMJD6-IN-1 can be used for the research of lung adenocarcinoma, prostate cancer, breast cancer, pancreatic cancer, colon cancer, oral squamous cell carcinoma, and glioblastoma .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
